BALYASNY ASSET MANAGEMENT L.P. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$7,670,235
-43.8%
199,954
-13.9%
0.01%
-45.8%
Q1 2024$13,651,244
-77.0%
232,243
-64.3%
0.02%
-81.7%
Q2 2023$59,321,496
+45.6%
651,169
+5.4%
0.13%
+28.4%
Q1 2023$40,756,486
+207.5%
617,897
+141.0%
0.10%
+183.3%
Q4 2022$13,255,393
+310.6%
256,341
+442.3%
0.04%
+260.0%
Q3 2022$3,228,000
-46.9%
47,265
-63.2%
0.01%
-52.4%
Q4 2021$6,076,000
+0.6%
128,514
-29.8%
0.02%
-16.0%
Q3 2021$6,037,000
+465.8%
183,147
+205.2%
0.02%
+400.0%
Q3 2018$1,067,000
-25.9%
60,000
-8.3%
0.01%
-28.6%
Q2 2018$1,439,00065,4280.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders